Article

Sleep apnea-glaucoma correlation merits further study

Sleep apnea is associated with many eye diseases. While contradictory evidence exists of an association with glaucoma, it cannot be ruled out.

Sleep apnea is associated with many eye diseases. While contradictory evidence exists of an association with glaucoma, it cannot be ruled out.

Since sleep apnea is a common condition, ophthalmologists should consider sleep evaluations in patients with normal tension glaucoma, glaucoma, pseudotumor cerebri, atypical retinal hemorrhages, and retinal vascular tortuosity, said Parag A. Gokhale, MD, assistant professor of ophthalmology, Medical College of Georgia, Augusta.

"I do believe that sleep apnea is a risk factor for glaucoma, and in my glaucoma patients I do take a brief sleep history and refer patients for sleep studies if their histories are positive," Dr. Gokhale said.

He noted that while a number of studies have found an association between sleep apnea and glaucoma, others have not. Studies have used varying definitions of sleep apnea and glaucoma and have displayed variability in their control groups. Therefore, it is difficult to reach definitive conclusions with the available evidence, Dr. Gokhale said.

He recommended clinical trials with age- and weight-matched control groups. He also suggested that, just as ophthalmologists should look for signs of sleep disorders in their glaucoma patients, clinicians should also evaluate sleep-disordered patients for signs of glaucoma.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.